Skip to main content

BMJ Journals

  • Log In More
    Log in via Institution
    Log in via OpenAthens

    Log in using your username and password

    For personal accounts OR managers of institutional accounts
    Forgot your log in details?Register a new account?
    Forgot your user name or password?
  • Basket
  • Search More
    Advanced search
Journal for ImmunoTherapy of Cancer
  • Latest content
  • Browse by topic
  • Archive
  • Authors
  • About

Advanced search

  • Close More

    Main menu

    • Latest content
    • Browse by topic
    • Archive
    • Authors
    • About
  • Log in More
    Log in via Institution
    Log in via OpenAthens

    Log in using your username and password

    For personal accounts OR managers of institutional accounts
    Forgot your log in details?Register a new account?
    Forgot your user name or password?
  • BMJ Journals More

You are here

  • Home
  • topic
  • Journal for ImmunoTherapy of Cancer
  • Special collections
  • JITC
  • Immune Checkpoint Series
Email alerts

Immune Checkpoint Series

  • Special collections /
  • JITC /
  • Immune Checkpoint Series
  • LAG-3: from molecular functions to clinical applications
    Takumi Maruhashi, Daisuke Sugiura, Il-mi Okazaki, Taku Okazaki
    Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e001014; DOI: 10.1136/jitc-2020-001014
  • TIGIT in cancer immunotherapy
    Joe-Marc Chauvin, Hassane M Zarour
    Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e000957; DOI: 10.1136/jitc-2020-000957
  • Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
    Christopher A Chuckran, Chang Liu, Tullia C Bruno, Creg J Workman, Dario AA Vignali
    Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000967; DOI: 10.1136/jitc-2020-000967
  • On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
    Thilo Gambichler, Judith Reuther, Christina H Scheel, Jürgen Christian Becker
    Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e001145; DOI: 10.1136/jitc-2020-001145
  • Tim-3 finds its place in the cancer immunotherapy landscape
    Nandini Acharya, Catherine Sabatos-Peyton, Ana Carrizosa Anderson
    Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000911; DOI: 10.1136/jitc-2020-000911
  • Lifting the innate immune barriers to antitumor immunity
    Carla V Rothlin, Sourav Ghosh
    Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000695; DOI: 10.1136/jitc-2020-000695
  • Master protocols in immuno-oncology: do novel drugs deserve novel designs?
    Luca Mazzarella, Stefania Morganti, Antonio Marra, Dario Trapani, Giulia Tini, Piergiuseppe Pelicci, Giuseppe Curigliano
    Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000475; DOI: 10.1136/jitc-2019-000475
  • On the mechanism of anti-CD39 immune checkpoint therapy
    David Allard, Bertrand Allard, John Stagg
    Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000186; DOI: 10.1136/jitc-2019-000186
  • Monalizumab: inhibiting the novel immune checkpoint NKG2A
    Thorbald van Hall, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Emilie Narni-Mancinelli, Sjoerd H. van der Burg, Eric Vivier
    Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 263; DOI: 10.1186/s40425-019-0761-3
  • Special collections
    • COVID-19 (17)
    • Editor's choice
    • JITC
      • Basic Tumor Immunology (103)
      • Case Reports (20)
      • Clinical Trials Monitor (1)
      • Clinical/Translational Cancer Immunotherapy (186)
      • Commentary/Editorials (19)
      • COVID-19 and Cancer Immunotherapy
      • Emerging Immunotherapeutic Agents (5)
      • Guidelines and Consensus Statements
      • Immune Cell Therapies and Immune Cell Engineering (37)
      • Immune Checkpoint Series (9)
      • Immune Checkpoints - Beyond PD-1
      • Immune Monitoring Technology Primers (12)
      • Immunotherapy Biomarkers (64)
      • Microbial-Based Cancer Immunotherapy (4)
      • Oncolytic and Local Immunotherapy (20)
      • Position Articles and Guidelines (26)
      • Reviews (36)
    • Open access (1430)
    • Press releases
  • Society for Immunotherapy of Cancer
  • Content
    • Latest content
    • Browse by topic
    • Archive
  • Journal
    • About
    • Editorial board
    • Thank you to our reviewers
    • Sign up for email alerts
  • Authors
    • Instructions for authors
    • Submit an article
    • Open Access at BMJ
  • Help
    • Contact us
    • Reprints
    • Permissions
    • Advertising
    • Feedback form
  • RSS
  • Twitter
  • Website Terms & Conditions
  • Privacy & Cookies
  • Contact BMJ

Online: ISSN 2051-1426
Copyright © 2020 BMJ Publishing Group Ltd & Society for Immunotherapy of Cancer. All rights reserved.
京ICP备15042040号-3